Results 161 to 170 of about 12,098 (189)

Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi.

JAMA Dermatol, 2021
Robertson SJ, Orme L, Teixeira R, Shamassi M, Newell F, Patch AM, Yeh I, Gard G, Wilmott J, Jackett L, LeBoit P, Fellowes A, MacArthur G, Fox S, Hayward NK, Bastian B, Scolyer R, Waddell N, Penington A, Shackleton M.   +19 more
europepmc   +1 more source

Entrectinib as first-line vs. second-line therapy in ROS1 fusion-positive non-small cell lung cancer: a cost-effectiveness analysis. [PDF]

Transl Lung Cancer Res
Huo G, Song Y, Chen X, Chen P.
europepmc   +1 more source

41P The influence of ROS1 fusion partners and resistance mechanisms in ROS1-TKI treated NSCLC patients

ESMO Open
Zwierenga, Fenneke, Dijkhuizen, C., Korthuis, P., van den Berg, A., Timens, W., Groen, H.J.M., Hiltermann, T.J.N., Drayer, L., Wekken, A.J. Van Der   +8 more
openaire   +2 more sources

MIG6 Mediates Adaptive and Acquired Resistance to ALK/ROS1 Fusion Kinase Inhibition through EGFR Bypass Signaling. [PDF]

Mol Cancer Ther
Chen N, Tyler LC, Le AT, Welsh EA, Fang B, Elliott A, Davies KD, Danhorn T, Riely GJ, Ladanyi M, Haura EB, Doebele RC.   +11 more
europepmc   +1 more source

Molecular and immune biomarker testing in squamous-cell lung cancer: Effect of current and future therapies and technologies [PDF]

, 2018
Bradley, Jeffrey D, et al,
core   +1 more source

Economic Evaluation of Targeted Therapies for Anaplastic Lymphoma Kinase- and ROS1 Fusion-Positive Non-Small Cell Lung Cancer in India. [PDF]

JCO Glob Oncol
Gupta D, Gupta N, Singh N, Prinja S.
europepmc   +1 more source

Myeloproliferative neoplasm harboring both monosomy 7 and an ALK/ROS1 fusion gene: Proposal for a new disease entity. [PDF]

EJHaem
Yoshida H, Osone S, Konishi M, Tanaka S, Inaba T, Imamura T, Iehara T.   +6 more
europepmc   +1 more source

Taletrectinib: TRUST in the Continued Evolution of Treatments for <i>ROS1</i> Fusion-Positive Lung Cancer. [PDF]

J Clin Oncol
Waliany S, Lin JJ.
europepmc   +1 more source

Serial Cell-Free DNA Sequencing in <i>ROS1</i> Fusion-Positive Lung Cancers During Treatment With Entrectinib. [PDF]

JCO Precis Oncol
Choudhury NJ, Jun Woo H, Chen M, Shah R, Donoghue M, Berger M, Drilon A.   +6 more
europepmc   +1 more source